Liver-Directed Adeno-Associated Virus-Mediated Gene Therapy for Mucopolysaccharidosis Type VI.
- DOI
- 10.1056/evidoa2200052
- Published
- 2022 Jul
- Container
- NEJM evidence
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1056/evidoa2200052,
title = {Liver-Directed Adeno-Associated Virus-Mediated Gene Therapy for Mucopolysaccharidosis Type VI.},
author = {Brunetti-Pierri N and Ferla R and Ginocchio VM and Rossi A and Fecarotta S and Romano R and Parenti G and Yildiz Y and Zancan S and Pecorella V and Dell'Anno M and Graziano M and Alliegro M and Andria G and Santamaria F and Brunetti-Pierri R and Simonelli F and Nigro V and Vargas M and Servillo G and Borgia F and Soscia E and Gargaro M and Funghini S and Tedesco N and Le Brun PR and Rupar CA and Prasad C and O'Callaghan M and Mitchell JJ and Danos O and Marteau JB and Galimberti S and Valsecchi MG and Veron P and Mingozzi F and Fallarino F and la Marca G and Sivri HS and Auricchio A},
year = {2022},
journal = {NEJM evidence},
doi = {10.1056/evidoa2200052},
url = {https://doi.org/10.1056/evidoa2200052}
}RIS
TY - JOUR TI - Liver-Directed Adeno-Associated Virus-Mediated Gene Therapy for Mucopolysaccharidosis Type VI. AU - Brunetti-Pierri N AU - Ferla R AU - Ginocchio VM AU - Rossi A AU - Fecarotta S AU - Romano R AU - Parenti G AU - Yildiz Y AU - Zancan S AU - Pecorella V AU - Dell'Anno M AU - Graziano M AU - Alliegro M AU - Andria G AU - Santamaria F AU - Brunetti-Pierri R AU - Simonelli F AU - Nigro V AU - Vargas M AU - Servillo G AU - Borgia F AU - Soscia E AU - Gargaro M AU - Funghini S AU - Tedesco N AU - Le Brun PR AU - Rupar CA AU - Prasad C AU - O'Callaghan M AU - Mitchell JJ AU - Danos O AU - Marteau JB AU - Galimberti S AU - Valsecchi MG AU - Veron P AU - Mingozzi F AU - Fallarino F AU - la Marca G AU - Sivri HS AU - Auricchio A PY - 2022 JO - NEJM evidence DO - 10.1056/evidoa2200052 UR - https://doi.org/10.1056/evidoa2200052 ER -
APA
N, B., R, F., VM, G., A, R., S, F., R, R., G, P., Y, Y., S, Z., V, P., M, D., M, G., M, A., G, A., F, S., R, B., F, S., V, N., M, V., G, S., F, B., E, S., M, G., S, F., N, T., PR, L. B., CA, R., C, P., M, O., JJ, M., O, D., JB, M., S, G., MG, V., P, V., F, M., F, F., G, L. M., HS, S., & A, A. (2022). Liver-Directed Adeno-Associated Virus-Mediated Gene Therapy for Mucopolysaccharidosis Type VI.. NEJM evidence. https://doi.org/10.1056/evidoa2200052
Source records
- pubmed · retrieved 2026-09-25T08:28:46.880Z
- europe-pmc · retrieved 2026-09-25T08:28:47.339Z